 two-drug therapi patient metastat germ cell tumor eighty-two patient metastat germ cell tumor gct two-drug therapi consist etoposid cisplatin late relaps good-risk gct memori sloan-kett cancer center mskcc criteria etoposid day cisplatin day therapi day delay day leukocyt count platelet count drug dose myelosuppress seventy-six evalu patient complet respons CR seventy-two patient CR forty-six patient excis residu abnorm resect specimen necrot debri fibrosi CR chemotherapi complet excis residu viabl gct six patient incomplet respons chemotherapi patient unresect matur teratoma progression-fre median etoposid dose standard deviat SD median cisplatin dose SD nine patient relaps month patient nonseminomat gct chemotherapi patient seminoma chemotherapi radiat therapi patient addit therapi disease-fre month patient disease-fre median follow-up time month rang month relaps month etoposid cisplatin therapi dose schedul result durabl CR late relaps